Stay updated on SAGE-217 for MDD Relapse Prevention Clinical Trial

Sign up to get notified when there's something new on the SAGE-217 for MDD Relapse Prevention Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SAGE-217 for MDD Relapse Prevention Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-18T22:34:46.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The record history now includes a new revision entry v3.4.3 and removes the previous entry v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T19:57:45.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    42 days ago
    Change Detected
    Summary
    A new site revision entry (v3.4.2) was added. The previous funding-lapse notice (v3.4.1) was removed.
    Difference
    0.7%
    Check dated 2026-02-11T04:40:09.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding lapse and operating status, and updated the record history to Revision: v3.4.1. The previous Revision: v3.4.0 entry was removed.
    Difference
    0.8%
    Check dated 2026-02-04T03:23:12.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The history page now includes a glossary option and updated explanations for color-coded changes (green for additions and red for deletions) with a new Revision: v3.4.0. The No FEAR Act data label was adjusted and the previous Revision: v3.3.4 entry was removed.
    Difference
    1.0%
    Check dated 2026-01-28T00:35:55.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Added a new Revision: v3.3.3 entry to the study history and removed the HHS Vulnerability Disclosure and Revision: v3.3.2 from the page.
    Difference
    0.2%
    Check dated 2025-12-23T08:19:14.000Z thumbnail image

Stay in the know with updates to SAGE-217 for MDD Relapse Prevention Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SAGE-217 for MDD Relapse Prevention Clinical Trial page.